Aquestive Therapeutics, Inc. (AQST)
4.065
-0.02
(-0.61%)
USD |
NASDAQ |
Apr 29, 11:37
Aquestive Therapeutics Research and Development Expense (TTM) : 17.19M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 117.30M |
| REGENXBIO, Inc. | 212.68M |
| Verastem, Inc. | 114.60M |
| Harrow, Inc. | 12.49M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |